Baylor College of Medicine

COVID-19 Trial to Combat Delta Variant

UT Health Science Center at Houston, Baylor College of Medicine and Johns Hopkins University are enrolling for two new Covid-19 treatment and prevention studies in the Houston metro area. If you have recently been diagnosed with COVID-19, you may be eligible, and participants will be compensated up to $575. This is the first U.S. multi-center, double-blind, randomized clinical trial to assess the effectiveness of convalescent blood plasma as an outpatient therapy. Antibodies are one of […]

Small U.S. Biotechnology Company Races To Acquire FDA Approval For Its Covid-19 Therapeutic, Which Is Showing Tremendous Positive Results In Those Severely Ill

CytoDyn Inc. (CytoDyn), a late-stage biotechnology company, announced today that it is currently accepting only 155 more candidates across the country for its Phase 2b/3 registrational trial in patients with severe-to-critical COVID-19. Three of the sites in Texas where CytoDyn is conducting its trial are University of Texas Health in Houston, Baylor College of Medicine in Houston and Baylor Scott & White Health in Dallas. CytoDyn has already registered 235 patients in its trial, and the Data Safety […]

AG Paxton Announces $2 Million Settlement Payment to Baylor College of Medicine for Pediatric Neurological Research

Ken Paxton

AUSTIN – Attorney General Ken Paxton today announced that the Baylor College of Medicine will receive $2 million from a settlement reached by Texas with Questcor Pharmaceuticals, Inc. Baylor College of Medicine will use the $2 million for funding related to innovative pediatric neurological research projects. In January, Texas, the Federal Trade Commission and four other state attorneys general resolved a lawsuit against Questcor alleging it monopolized the market for Acthar, the only adrenocorticotropic hormone […]